Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG

NAUnknownINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2022

Conditions
DiabetesDiabetic Retinopathy
Interventions
DIETARY_SUPPLEMENT

DVS supplementation

Oral supplement. Each subject will be given the carotenoid supplement of DVS formula. The DVS formula consists of vitamins C, D3 and E (d-α tocopherol), zinc oxide, eicosapentaenoic acid, docosahexaenoic acid, α-lipoic acid (racemic mixture), coenzyme Q10, mixed tocotrienols/tocopherols, zeaxanthin, lutein, benfotiamine, N-acetyl cysteine, grape seed extract, resveratrol, turmeric root extract, green tea leaf, and Pycnogenol (patented French Maritime Pine Bark extract, sp Pinus pinaster, Horphag Research, Geneva, Switzerland). Supplements bottles will be labelled with a unique identification number for each subject and supplied by ZeaVision, LLC, Chesterfield, Missouri, USA. To assure that the participants do not have any issues with the vitamin supplement and to ensure adequate adherence to schedule of vitamin intake the participants will get regular phone calls from the study investigators (once every two weeks).

Trial Locations (2)

74464

RECRUITING

Oklahoma College of Optometry, Northeastern State University, Tahlequah

91766

RECRUITING

Western Universit5y of Health Sciences, College of Optometry, Pomona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Northeastern State University

OTHER

collaborator

Western University of Health Sciences

OTHER

collaborator

Diopsys, Inc.

INDUSTRY

lead

ZeaVision, LLC

INDUSTRY